Governance Across Research, Quality and Information Technology
Integrated Governance Framework
Effective governance requires coordination across research, quality, and information technology functions. In pharmaceutical organisations, this integration ensures that AI systems meet regulatory expectations while maintaining data integrity standards. The governance framework must establish clear roles and responsibilities for each department. Research teams develop AI models, quality assurance teams validate their performance, and IT departments manage the underlying infrastructure. A clinical research organisation might implement a three-tier governance structure where research leads oversee model development, quality specialists review validation protocols, and IT staff ensure system security and data protection. This approach prevents siloed decision-making that could compromise regulatory compliance or data integrity.
The framework should include regular cross-functional meetings to discuss AI implementation progress. These sessions help identify potential issues before they escalate. A pharmaceutical company developing AI for drug discovery might schedule monthly governance reviews involving research scientists, quality assurance specialists, and IT security personnel. During these meetings, teams discuss model performance metrics, data quality concerns, and any system updates that might affect regulatory compliance. The governance committee ensures that all activities align with established protocols and that any deviations are properly documented and reviewed.
Quality Management Integration
Quality management systems must incorporate AI validation processes alongside traditional testing procedures. The quality assurance department plays a central role in ensuring that AI systems meet required standards throughout their lifecycle. In clinical trial design, AI algorithms used for patient selection must undergo the same validation processes as other clinical tools. The quality team reviews validation protocols to ensure they cover data integrity aspects, algorithmic bias, and performance consistency. A quality manager might require that AI validation includes testing with diverse patient datasets to prevent discriminatory outcomes.
The validation process should include regular audits of AI systems to verify ongoing compliance. These audits examine whether the AI continues to meet established performance criteria and data integrity requirements. A pharmaceutical manufacturer using AI for batch release decisions might conduct quarterly validation reviews that check algorithm accuracy against historical data. The quality team documents these reviews and ensures that any identified issues are addressed through appropriate corrective actions. This systematic approach maintains consistent quality standards while adapting to changing regulatory expectations.
Information Technology Oversight
IT departments must implement security measures that protect AI systems and maintain data integrity throughout the research process. Network security protocols should prevent unauthorised access to AI models and training data. In a clinical research environment, IT staff might establish encrypted data transfer protocols between research facilities and central data repositories. These measures protect sensitive patient information while enabling collaborative research activities. The IT team also manages access controls that ensure only authorised personnel can interact with AI systems.
Data management practices must support AI development while meeting regulatory requirements. IT infrastructure should accommodate large datasets required for machine learning algorithms while maintaining audit trail capabilities. A pharmaceutical company implementing AI for adverse event detection might establish data retention policies that preserve clinical records for regulatory inspection purposes. The IT department coordinates with research teams to ensure that data storage solutions meet both operational needs and compliance requirements. Regular system backups and disaster recovery procedures protect against data loss that could compromise research integrity or regulatory submissions.
The integration of governance across these three areas creates a unified approach to AI management. Regular communication between research, quality, and IT functions ensures that AI systems develop within established frameworks. This coordinated approach helps organisations maintain regulatory compliance while advancing AI capabilities. The governance framework provides structure for addressing challenges that arise during AI implementation. Regular reviews and updates to governance processes ensure that they remain effective as AI technologies evolve. This systematic approach protects organisational interests while supporting innovation in pharmaceutical research.